BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Effient prasugrel: Phase II data

The double-blind, U.S. Phase II SWAP trial in 100 evaluable patients showed that switching to maintenance dosing with Effient plus aspirin from maintenance dosing with Plavix clopidogrel plus aspirin within 30-330 days following an ACS event met the primary endpoint of significantly reducing MPA at day 7 vs....

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >